News & Events
May 19, 2021 - May 20, 2021
View Now | 2021 PKD Regulatory Summit | May 19-20
Join C-Path’s PKDOC and The PKD Foundation for the 2021 PKD Regulatory Summit on May 19 and 20. Together with key stakeholders from around the world, the consortium will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments.
May 7, 2021
VIEW NOW: COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual WorkshopThe Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual workshop on COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials held on May 7, 2021. Objectives for the workshop included: Identifying challenges to conducting pediatric rare disease clinical trials posed by COVID-19 Presenting a range of strategies......
April 21, 2021
View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis
When: April 21, 2021, 12 p.m. ET
Example Disease: Friedreich’s ataxia
Presenters: Amanda Borens, MSc, Executive Director, Data Science, DCC; Vicki Theurer Crider, Sr. Project Manager, DCC; Kurt Michels, Data Analyst, Data Science
April 14, 2021
View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held VirtuallyApril 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual format. The following Workshop Agenda provides an overview of the two-day meeting as well as links to the session recordings and slide decks. Links to posters summarizing the status of the PRO Consortium’s working groups, the Rare Disease......
March 31, 2021
View Now: 2021 PSTC Virtual Workshop—March 31, 2021The Predictive Safety Testing Consortium (PSTC) launched its 15th anniversary celebration with a virtual public workshop. Scientists and experts from the U.S. Food and Drug Administration (FDA), the pharmaceutical industry, academia, and Critical Path Institute (C-Path) discussed PSTC’s work in the regulatory space, its current efforts in researching fluid biomarkers as predictive tools of drug-induced......